ABSTRACT
INTRODUCTION
Aging is traditionally thought to be caused by numerous complex and interacting factors. These include oxidative DNA damage, depletion of selfrenewing stem cells, mitochondrial and nuclear genome mutations, especially in DNA repairs genes, shortening of telomeres, and other processes (Kirkwood 2005) . Human aging has not been fully understood in terms of the genetic setting. Epigenetic profile is an alternative mean of explaining age-associated alterations. In fact, an increasing body of evidence suggests that many manifestations of aging are epigenetic (Koch and Wagner 2011; Huidobro et al. 2013) . Epigenetics is defined as the "study of stable genetic modifications that result in changes in gene expression and function without a corresponding alteration in DNA sequence'' (Probst et al. 2009 ). Epigenetic mechanisms comprise DNA methylation, post-translational histone modifications, and non-coding RNAs, and they are related to gene expression and chromatin structure. Among epigenetic modifications, DNA methylation has been best characterized. CpG dinucleotides in the mammalian genome can be enzymatically methylated at cytosines by at least three DNA methyltransferases (DNMTs) (DNMT1, DNMT3A and DNMT3B). Dinucleotides CpG ''methylable'' are not randomly distributed in the human genome; they appear in CpG-poor regions and CpG-rich regions denominated as CpG islands, which are present in the promoters of many genes. DNA methylation is a crucial mechanism in the control of gene activity and nuclear architecture (Portela and Esteller 2010) . Studies have shown that DNA methylation changes during the aging of blood cells (Tra et al. 2002; Fuke et al. 2004; Gowers et al. 2011; Heyn et al. 2012; Madrigano et al. 2012) , skin (Raddatz et al. 2013 ) muscle (Zykovich et al. 2013 ) and saliva (Bocklandt et al. 2011 ). Periodontitis and cancer are age-related diseases in which epigenetic mechanisms are involved (Oliveira et al. 2009; Towle et al. 2013) . hTERT codifies catalytic subunit of telomerase, which is involved in replicative life span regulation by maintaining telomere length (Poole et al. 2001) . MLH1 (mutL homolog 1) codifies a component of the principal DNA repair pathways that contributes to genomic stability by targeting base-base mismatches and insertion/deletion loops occurring during replication, homologous recombination and DNA damage (Schofield and Hsieh 2003) . Methylenetetrahydrofolate reductase (MTHFR), a key enzyme in folate metabolism, is involved in the generation of Sadenosylmethionine (SAM), the universal methyl donor for methylation reactions (Ly et al. 2012) . Based on these facts, it was hypothesed that DNA methylation status in two genes involved in tumorigenesis (hTERT and MLH1) and one in metabolism (MTHFR) could be influenced by aging and here the focus was on oral epithelial cells.
MATERIALS AND METHODS

Subject Population
Prior to commencement, the study design was approved by the Institutional Review Board of the Federal University of Paraiba (protocol number 149/12). All the volunteers were informed about the nature of the proposed study and written consent was taken from all. A convenience sample of unrelated male and female subjects was recruited for the study. All the subjects were in good general health. The exclusion criteria included the individuals with a history of oral cancer, with clinical signs of damage to the oral mucosa and smokers. It was noted that the mouthwash of some elderly had little bleeding. Sixty-five subjects aged 06-69 years old were enrolled in the study.
Sample Collection
The subjects were classified into one of three categories based on their age. Of these, 21 were children (mean age: 8.24 ± 1.50 years; mean±SD; 47.72% boys and 52.28% girls), 19 were young (mean age: 21.52 ± 1.81years; 52.63% men and 47.37% women) and 25 were elderly (mean age: 64.84 ± 4.56 years; 28% men and 72% women). Oral epithelial cell samples were collected and the DNA was purified as previously described (de Arruda et al. 2013) .
DNA Methylation Analysis
Methylation analysis was performed by Methylation Sensitive Restriction Enzymes (MSRE). Polymerase chain reaction (PCR) analysis, relying on the inability of restriction enzymes to cut methylated sequences. The sites examined were recognized by one of the following restriction enzymes, whose activity was always blocked by CpG methylation: HhaI and HpaII.
DNA digestion
Genomic DNA (50 ng) was completely digested with the restriction enzymes in a total volume of 20 µL, as recommended by the manufacturer (New Englands Biolabs, Beverly, MA). The reaction of each restriction enzyme was conducted in an individual manner. The concentrations of the restriction enzymes, as well as the amount of DNA to be digested, have been previously described and calculated (Hashimoto et al. 2007 ).
DNA amplification
A semi-quantitative PCR technique was performed in order to compare methylation levels in the different groups. Therefore, a specific number of cycles of the PCR reaction was defined at the exponential phase of amplification. hTERT: After digestion, 4.8 µL (12 ng antisense (5´-TTACACTAATCCCGCGAAGG-3´), with 392 bp (GenBank accession number AF257484.1). The PCR was performed under the following conditions: 35x (95°C, 1min; 55°C, 1 min; 72°C, 1 min).
Electrophoresis
Amplified PCR samples (6.0 µL) were carried on 6% polyacrylamide gels and subjected to electrophoresis. DNA bands were detected after Gel Red (Biotium) stain. Amplified DNAs of hTERT, MLH1 and MTHFR genes were used as controls for restriction enzymes. An input of 50 ng of amplified DNA was submitted for the restriction of each enzyme to ensure their effectiveness. The non-enzyme-treated control DNA sample was always amplified with the primers, in parallel with the enzyme-treated samples, and both were subjected to electrophoresis in adjacent lanes. This provided a positive control for the PCR reaction and for DNA loading.
Statistical Analysis
Differences among groups were compared by χ 2 Test at level of 5%.
RESULTS AND DISCUSSION
In the present study, Methylation Sensitive Restriction Enzymes were used as methodology. Thus, PCR amplification absence indicated the absence of methylation and the presence of bands indicated partial or total DNA methylation. Here, partially methylated samples were considered as methylated. It must also be noted that besides buccal epithelial cells, the salivary rinses could also contain some other cells such as neutrophils and monocytes, especially in the elderly persons who had periodontitis. However, the concern was collecting the cells from the buccal mucosa, which had no clinical signs of inflammation, but the possibility of the presence of changes in gingival tissue in the elderly persons could not be ruled out. In fact, it was observed that the mouthwash of some elderly persons had little bleeding. There was loss of DNA methylation during the aging of oral cells for hTERT gene promoter but not for MLH1 neither MTHFR. The results for each CpG site (gcgc and ccgg) are shown in Figures 1, 2 and 3 . hTERT -The CpG dinucleotides investigated in the hTERT gene promoter ranging from -697 to -337. These regions respond to transcription factors such as NF-kB and Sp-1 (Cong et al. 1999 ). In addition, this presented typical CpG islands near the transcriptional start site. There was one CpG island located in the promoter of hTERT, as verified by MethPrimer Software. The results showed difference between the conditions, methylated and unmethylated among the groups. Previous study with normal cells also showed DNA hypomethylation with advancing age from the peripheral blood analysis of young and elderly subjects (Silva et al. 2008) . Another study with normal tissue (bladder, brain, heart, kidney, muscle, and placenta) showed hypomethylation in the proximal hTERT promoter (ranging -500 to +300). However, in this case, tissue age was not revealed (Guilleret and Benhattar 2004) . In relation to oral cells, one study analyzed the cells obtained from gingival tissues and kept in culture {fibroblasts (NHOF) and senescent normal oral keratinocytes (NHOK)}. The assay revealed that the hTERT promoter was hypermethylated in NHOF and was gradually methylated during senescence in NHOK (Shin et al. 2003) . In tumoral cells, the hypermethylation condition was more frequent and it was already shown in breast, bladder, colon, kidney (Guilleret and Benhattar, 2004 ), brain (Castelo-Branco et al. 2013 ) and in leptomeningeal metastasis (Bougel et al. 2013) . Interestingly, some studies have shown an inverse relationship to the well-established model in which the methylation presence generally inhibits gene transcription, that is, hypermethylation is associated with hTERT gene expression. This was observed in tumoral and healthy cells (Devereux et al. 1999; Guilleret et al. 2002; Widschwendter et al. 2004 ) and suggested that the region of the promoter studied was not the main regulatory sequence and/or possibly another mechanism such as histone modifications could regulate gene expression of hTERT. Iliopoulos et al. (2009) have shown that both mechanisms are involved in the hTERT regulation. In contrast, some studies with both normal and tumoral cells found a relationship between hypomethylation and gene transcription activation, checked by the treatment with the demethylating agent, 5-Aza-2-deoxycytidine (Shin et al. 2003; Iliopoulos et al. 2009 ). Daniel et al. (2012) suggested that the broad range of mechanisms by which hTERT was regulated in both cancer and normal cells reinforced the need for further studies about hTERT. MLH1-The CpG dinucleotide selected for MLH1 gene promoter analysis were located near the region between nucleotides -670 and -81. These nucleotides were located within two CpG islands as verified by MethPrimer Software. This region has binding sites for several transcription factors such as AP-1, NF-қB, OCT-1, OCT-2, Sp-1, p53 and other (Kane et al. 1997) . In this work, eight CpG sites were studied, four recognized by the enzyme HhaI and four recognized by HpaII enzyme. The DNA methylation status was similar for all the groups. Recent work with healthy subjects showed that in blood cells, there was loss of methylation in the promoter of the MLH1 gene with advancing age and also the methylation profile was associated with the type of polymorphism in the same gene (Savio et al. 2012) . In the present study, no loss of DNA methylation in oral cells was detected. Other studies have found changes in the DNA methylation of MLH1 gene compared with healthy individuals with individuals with cancer, and hypermethylation was detected in colorectal cancer (Kane et al. 1997) , gastric cancer (Alves et al. 2011) , esophagic cancer (Ling et al. 2011 ) and lung cancer (Gomes et al. 2014) . These studies also found association between hypermethylation and gene repression. In relation to cancer in the oral cavity, the results are controversial. Hypermethylation has been shown in many cases of oral cancer at early stages and in half the cases in the later stages of the disease, suggesting that the methylation of MLH1 gene promoter is an early event and is maintained during tumor progression (Czerninski et al. 2009; González-Ramirez et al. 2011) . In contrast, other authors have shown low rate of MLH1 methylation in oral carcinomas (Ogi et al. 2002; Viswanathan et al. 2003) . It has been reported that the differences between results may be a consequence of the different stages of development and progress of the sample studied. (Botezatu et al. 2014) . Some studies have suggested the possible involvement of MTHFR promoter methylation in the pathogenesis of end-stage renal disease patients (Ghattas et al. 2014 ) and in cervical severity lesions (Botezatu et al. 2013a) . Most of the studies have been performed with blood cells and both hypomethylation and hypermethylation were to be associated with aging of healthy individuals (Tra et al. 2002; Fuke et al. 2004; Gowers et al. 2011; Heyn et al. 2012; Madrigano et al. 2012) . In aged skeletal muscle, hypermethylation was found in comparison to samples of younger people (Zykovich et al. 2014) . Aged skin revealed no global aberrations, but rather highly localized methylation changes, particularly in promoter and enhancer regions that were associated with altered transcriptional activity (Raddatz et al. 2013) . In saliva, DNA methylation of three sites of the EDARADD, TOM1L1 and NPTX2 gene promoters were linear with age over a range of five decades and it was able to predict the age of an individual with an average accuracy of 5.2 years (Bocklandt et al. 2011) . In the present study, there was loss of methylation during the aging of oral cells in the promoter of hTERT and it was detected between young and elderly. However, it lacked between 21 and 60 years old and it was not known when this started to happen exactly.
MTHFR-
For both MLH1 and MTHFR, the unmethylated condition was the usual aspect of DNA methylation status for oral epithelial cells and it was not influenced by the aging. However, for some individuals, the methylated condition was noted. It could be associated to others factors that also influenced the DNA methylation status, such as diet, exposition to a variety of compounds (Cortessis et al. 2012 ) and polymorphisms in DNMTs, MTHFR and MLH1 (McKay et al. 2012; Savio et al. 2012; Inoue-Choi et al. 2013) . The wide range of characteristics (hypomethylation and hypermethylation), typically associated with the aging process could be explained by some studies. Vertino and collaborators (1994) suggested that DNA methyltransferase (DNMT) activity decreased with the age. However, the study was focused on each of the DNMTs present in mammals, the gene expression of DNMT1 and DNMT3a decreased, whereas mRNA amounts of DNMT3B notably increased (Casillas et al. 2003) . It has become increasingly frequent that DNA methylation is a promising marker for studying human development, aging and cancer and to tailor interventions based on the epigenetic status. It has already been suggested that access age by DNA methylation status could be useful for forensic science; such a model could estimate the age of a person, based on a biological sample alone (Bocklandt et al. 2011; An et al. 2013 ). However, as already suggested, it still remains to be studied whether the DNA methylation age of easily accessible fluids/tissues (for example, saliva, buccal cells, blood) could serve as a surrogate marker for inaccessible tissues (for example, brain, kidney and liver) (Horvath 2013) , since DNA methylation status is tissue-specific (Slieker et al. 2013) .
CONCLUSIONS
It was concluded that DNA methylation status of hTERT gene promoter of oral cells could be a promising marker for screening a set of agerelated alterations.
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